Uncategorized

Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership

Moderna’s mRNA flu shot wins unanimous support at FDA adcomm in rebuke of former leadership

Published

on

The FDA in February briefly refused to review Moderna’s flu vaccine, citing trial inadequacies, but reversed course a few days later. A verdict is expected by Aug. 5.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version